Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-04

Clinical Trial Update: Impact of Intrathecal Morphine on Sleep Apnea Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the impact of intrathecal morphine on sleep apnea syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intrathecal morphine (morphine)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Sleep Apnea Syndromes | Phase 4 | Status: COMPLETED